Joan How

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 11

Top Topics

Multiple Myeloma

Inflammatory Response

End Stage Renal Disease

Prognostic Factors

Top Venues

Postgraduate medicine

American journal of hematology

This page only lists publications with an associated author ORCID identifier.

Publications

Petra Bachanová, Joan How, Richard Dzeng, Sonia Mukherjee, Maia Pavlovic, Jennifer Lombardi, Gabriela S Hobbs, Patrick M Reeves
Immune profiling of responses to influenza vaccination in patients with myeloproliferative neoplasms. EJHaem 5 (3) (2024)
Rathnam K Venkat, Robert A Redd, Amyah C Harris, Martin J Aryee, Anna E Marneth, Baransel Kamaz, Chulwoo J Kim, Mohammed Wazir, Lachelle Dawn Weeks, Maximilian Stahl, Daniel J DeAngelo, R Coleman Lindsley, Marlise R Luskin, Gabriela S Hobbs, Joan How
Risk of Bleeding in Essential Thrombocythemia Patients with Extreme Thrombocytosis. Blood advances (2024)
Petra Bachanová, Joan How, Richard Dzeng, Sonia Mukherjee, Maia Pavlovic, Jennifer Lombardi, Gabriela S Hobbs, Patrick M Reeves
Immune profiling of responses to influenza vaccination in patients with myeloproliferative neoplasms. EJHaem 5 (3) (2024)
Joan How, Kathleen M E Gallagher, Yiwen Liu, Katelin Katsis, Eva L Elder, Rebecca C Larson, Mark B Leick, Donna S Neuberg, Marcela V Maus, Gabriela S Hobbs
Antibody and T-cell responses to SARS-CoV-2 vaccination in myeloproliferative neoplasm patients. Leukemia 36 (4) (2022)
Joan How, Siyang Ren, Jennifer Lombardi-Story, Meghan Bergeron, Julia Foster, Phillip C Amrein, Andrew M Brunner, Amir T Fathi, Hanno Hock, Anna Khachatryan, Hiroto Kikuchi, Mei Rosa Ng, Jenna Moran, Rupa Narayan, Donna Neuberg, Aura Ramos, Tina Som, Meghan Vartanian, Yi-Bin Chen, Dan G Duda, Gabriela S Hobbs
A nonrandomized phase I and biomarker trial of regorafenib in advanced myeloid malignancies. EJHaem 3 (2) (2022)
Joan How, Charlotte M Story, Siyang Ren, Donna S Neuberg, Rachel P Rosovsky, Gabriela S Hobbs, Jean Marie Connors
Practice patterns and outcomes of direct oral anticoagulant use in myeloproliferative neoplasm patients. Blood cancer journal 11 (11) (2021)
Vivek Naranbhai, Claire A Pernat, Alexander Gavralidis, Kerri J St Denis, Evan C Lam, Laura M Spring, Steven Jay Isakoff, Jocelyn R Farmer, Leyre Zubiri, Gabriela S Hobbs, Joan How, Andrew M Brunner, Amir T Fathi, Jennifer L Peterson, Mustafa Sakhi, Grace Hambelton, Elyssa N Denault, Lindsey J Mortensen, Lailoo A Perriello, Marissa N Bruno, Brittany Y Bertaux, Aleigha R Lawless, Monica A Jackson, Elizabeth Niehoff, Caroline Barabell, Christian N Nambu, Erika Nakajima, Trenton Reinicke, Cynthia Bowes, Cristhian J Berrios-Mairena, Onosereme Ofoman, Grace E Kirkpatrick, Julia C Thierauf, Kerry Lynn Reynolds, Henning Willers, Wilfredo-Garcia Beltran, Anand S Dighe, Rebecca R Saff, Kimberly G Blumenthal, Ryan J Sullivan, Yi-Bin Chen, Arthur Y Kim, Aditya Bardia, Alejandro B Balazs, A John Iafrate, Justin F Gainor
Immunogenicity and Reactogenicity of SARS-CoV-2 Vaccines in Patients With Cancer: The CANVAX Cohort Study. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2021)
Joan How, Charlotte M Story, Jean Marie Connors
Prevention of recurrent thromboembolism in myeloproliferative neoplasms: review of literature and focus on direct oral anticoagulants. Postgraduate medicine 133 (5) (2021)
Joan How, Gabriela S Hobbs
Use of Interferon Alfa in the Treatment of Myeloproliferative Neoplasms: Perspectives and Review of the Literature. Cancers 12 (7) (2020)
Joan How, Patrick Connor Johnson, Carleton Eduardo Corrales, Kyle Wright, Natalie Justicz, Jenny X Chen, Adam S Sperling, Nathan T Connell
Plasmacytoma presenting as jugular foramen tumor in a young woman with multiple myeloma. American journal of hematology 94 (6) (2019)
Joan How, Kathryn M Trinkaus, Stephen T Oh
Distinct clinical, laboratory and molecular features of myeloproliferative neoplasm patients with splanchnic vein thrombosis. British journal of haematology 183 (2) (2017)